Despite a surge in investor interest, UK life sciences remains a very niche real estate sub-sector. For the investment proposition to stack-up, the underlying occupier fundamentals must repay the risks associated with investing in an emerging sector. Despite some challenges, we believe this market offers very strong risk-adjusted returns for early-mover investors who can demonstrate a deep understanding of the underlying occupier market and build long-term relationships with key growth tenants.
Want more insights?
Want more insights?
Subscribe to receive the latest private markets perspectives and insights across all sectors directly to your inbox.
Related insights
- UK commercial real estate yields
- the-office-renaissance
- Real Estate Outlook – Switzerland, Edition 1H25
- If you want peace
- TRTPM monthly blog – Edition March 2025
- Harnessing climate data
- Adapting to economic trends in real estate
- Navigating real estate cycles
- Opportunities in UK commercial real estate
- TRTPM monthly blog – Edition February 2025
Contact us
Get in touch
Whether you have a question or a request, we will be happy to get in touch with you.